OptimizeRx (OPRX) Change in Acquisitions & Divestments (2023)

OptimizeRx (OPRX) posted Change in Acquisitions & Divestments of $53.6 million for Q4 2023, up 1.96% sequentially from $52.6 million in Q3 2023.

OptimizeRx (OPRX) Change in Acquisitions & Divestments (2023) Analysis & Trends

OptimizeRx has reported Change in Acquisitions & Divestments for 1 years, with the latest figure at $53.6 million in Q4 2023.

Quarterly Change in Acquisitions & Divestments changed N/A year-over-year to $53.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $218.7 million (changed N/A YoY) and the FY2023 annual result came in at $218.7 million, changed N/A from the prior year.
Change in Acquisitions & Divestments rose to $53.6 million in Q4 2023 per OPRX's latest filing, from $52.6 million in the prior quarter.
Over five years, Change in Acquisitions & Divestments peaked at $56.9 million in Q2 2023 and troughed at $52.6 million in Q3 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn
10	OptimizeRx	164.25 Mn	140.15 Mn	15.69 Mn

Download Data